The cytokine secretion could promote an increase in the proportion of CD8+ T cells and cytotoxic NK cells in PBMCs in vitro (Figure 5F), which could be reversed by applying the inhibitor to the co-culture system in PBRM1 mutant CRC cells (Figure 5G). Here, PBRM1 is linked to colorectal carcinoma.